US 8486370
Heterocyclic ligands for integrin imaging and therapy
granted A61KA61K51/0453A61K51/0455
Quick answer
US patent 8486370 (Heterocyclic ligands for integrin imaging and therapy) held by The Regents of the University of California expires Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jul 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 49
- CPC classes
- A61K, A61K51/0453, A61K51/0455, A61K51/0459, A61K9/0014